ZA200809172B - Maleate co-crystal of AZD1152 - Google Patents

Maleate co-crystal of AZD1152

Info

Publication number
ZA200809172B
ZA200809172B ZA200809172A ZA200809172A ZA200809172B ZA 200809172 B ZA200809172 B ZA 200809172B ZA 200809172 A ZA200809172 A ZA 200809172A ZA 200809172 A ZA200809172 A ZA 200809172A ZA 200809172 B ZA200809172 B ZA 200809172B
Authority
ZA
South Africa
Prior art keywords
azd1152
maleate
crystal
Prior art date
Application number
ZA200809172A
Other languages
English (en)
Inventor
George Joseph Sependa
Richard Storey
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36637528&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200809172(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of ZA200809172B publication Critical patent/ZA200809172B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/661Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA200809172A 2006-05-16 2008-10-24 Maleate co-crystal of AZD1152 ZA200809172B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0609621.8A GB0609621D0 (en) 2006-05-16 2006-05-16 Novel co-crystal

Publications (1)

Publication Number Publication Date
ZA200809172B true ZA200809172B (en) 2009-12-30

Family

ID=36637528

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200809172A ZA200809172B (en) 2006-05-16 2008-10-24 Maleate co-crystal of AZD1152

Country Status (22)

Country Link
US (1) US7625910B2 (US07585860-20090908-C00112.png)
EP (1) EP2027114A1 (US07585860-20090908-C00112.png)
JP (1) JP2009537498A (US07585860-20090908-C00112.png)
KR (1) KR20090009297A (US07585860-20090908-C00112.png)
CN (1) CN101448823A (US07585860-20090908-C00112.png)
AR (1) AR060963A1 (US07585860-20090908-C00112.png)
AU (1) AU2007251304A1 (US07585860-20090908-C00112.png)
BR (1) BRPI0712791A2 (US07585860-20090908-C00112.png)
CA (1) CA2650519A1 (US07585860-20090908-C00112.png)
CL (1) CL2007001388A1 (US07585860-20090908-C00112.png)
EC (1) ECSP088890A (US07585860-20090908-C00112.png)
GB (1) GB0609621D0 (US07585860-20090908-C00112.png)
IL (1) IL194862A0 (US07585860-20090908-C00112.png)
MX (1) MX2008014550A (US07585860-20090908-C00112.png)
NO (1) NO20084580L (US07585860-20090908-C00112.png)
RU (1) RU2008149242A (US07585860-20090908-C00112.png)
SA (1) SA07280243B1 (US07585860-20090908-C00112.png)
TW (1) TW200813026A (US07585860-20090908-C00112.png)
UA (1) UA95108C2 (US07585860-20090908-C00112.png)
UY (1) UY30351A1 (US07585860-20090908-C00112.png)
WO (1) WO2007132227A1 (US07585860-20090908-C00112.png)
ZA (1) ZA200809172B (US07585860-20090908-C00112.png)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE446093T1 (de) * 2001-12-24 2009-11-15 Astrazeneca Ab Substituierte chinazolin-derivate als aurora- kinase inhibitoren
JP4939220B2 (ja) * 2003-05-15 2012-05-23 アークル インコーポレイテッド p38の阻害物質としてのイミダゾチアゾール類およびイミダゾオキサゾール誘導体
EP2258704A1 (en) * 2004-10-19 2010-12-08 ArQule, Inc. Synthesis of imidazooxazole and imidazothiazole inhibitors of p38 map kinase
EP2013218A2 (en) * 2006-04-17 2009-01-14 Arqule, Inc. Raf inhibitors and their uses
WO2010065893A1 (en) * 2008-12-05 2010-06-10 Arqule, Inc. Raf inhibitors and their uses
HUE024568T2 (hu) * 2009-09-11 2016-02-29 Amgen Inc N-(4-((3-(2-amino-4-pirimidinil)-2-piridinil)oxi)fenil)-4-(4-metil-2-tienil)-1-ftalazinamin antimitotikus szerre rezisztens rák kezelésében történõ alkalmazásra
GB201007286D0 (en) 2010-04-30 2010-06-16 Astex Therapeutics Ltd New compounds
GB201020179D0 (en) 2010-11-29 2011-01-12 Astex Therapeutics Ltd New compounds
GB201118656D0 (en) 2011-10-28 2011-12-07 Astex Therapeutics Ltd New compounds
GB201118654D0 (en) 2011-10-28 2011-12-07 Astex Therapeutics Ltd New compounds
GB201118652D0 (en) 2011-10-28 2011-12-07 Astex Therapeutics Ltd New compounds
GB201118675D0 (en) 2011-10-28 2011-12-14 Astex Therapeutics Ltd New compounds
GB201209613D0 (en) 2012-05-30 2012-07-11 Astex Therapeutics Ltd New compounds
GB201209609D0 (en) 2012-05-30 2012-07-11 Astex Therapeutics Ltd New compounds
GB201307577D0 (en) 2013-04-26 2013-06-12 Astex Therapeutics Ltd New compounds
LT3046584T (lt) * 2013-09-16 2017-10-10 Astrazeneca Ab Terapinės polimerinės nanodalelės ir jų gamybos būdai ir panaudojimas
KR102479696B1 (ko) 2014-03-26 2022-12-22 아스텍스 테라퓨틱스 리미티드 Fgfr 억제제 및 igf1r 억제제의 조합물
JO3512B1 (ar) 2014-03-26 2020-07-05 Astex Therapeutics Ltd مشتقات كينوكسالين مفيدة كمعدلات لإنزيم fgfr كيناز
AU2015238301B2 (en) 2014-03-26 2020-06-25 Astex Therapeutics Ltd Combinations
JOP20200201A1 (ar) 2015-02-10 2017-06-16 Astex Therapeutics Ltd تركيبات صيدلانية تشتمل على n-(3.5- ثنائي ميثوكسي فينيل)-n'-(1-ميثيل إيثيل)-n-[3-(ميثيل-1h-بيرازول-4-يل) كينوكسالين-6-يل]إيثان-1.2-ثنائي الأمين
US10478494B2 (en) 2015-04-03 2019-11-19 Astex Therapeutics Ltd FGFR/PD-1 combination therapy for the treatment of cancer
BR112018005637B1 (pt) 2015-09-23 2023-11-28 Janssen Pharmaceutica Nv Compostos derivados de quinoxalina, quinolina e quinazolinona,composições farmacêuticas que os compreende, e uso dos referidos compostos
US11542247B2 (en) 2015-09-23 2023-01-03 Janssen Pharmaceutica Nv Bi-heteroaryl substitute 1,4-benzodiazepines and uses thereof for the treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE446093T1 (de) * 2001-12-24 2009-11-15 Astrazeneca Ab Substituierte chinazolin-derivate als aurora- kinase inhibitoren
DE60315892T2 (de) * 2002-12-24 2008-08-14 Astrazeneca Ab Phosphonooxy-chinazolin derivate und ihre pharmazeutische verwendung

Also Published As

Publication number Publication date
KR20090009297A (ko) 2009-01-22
SA07280243B1 (ar) 2010-12-01
MX2008014550A (es) 2008-11-27
US20080045481A1 (en) 2008-02-21
CL2007001388A1 (es) 2008-01-18
CA2650519A1 (en) 2007-11-22
JP2009537498A (ja) 2009-10-29
AR060963A1 (es) 2008-07-23
NO20084580L (no) 2009-02-05
UA95108C2 (en) 2011-07-11
AU2007251304A1 (en) 2007-11-22
UY30351A1 (es) 2008-01-02
BRPI0712791A2 (pt) 2012-09-04
ECSP088890A (es) 2008-12-30
CN101448823A (zh) 2009-06-03
EP2027114A1 (en) 2009-02-25
US7625910B2 (en) 2009-12-01
WO2007132227A1 (en) 2007-11-22
GB0609621D0 (en) 2006-06-21
TW200813026A (en) 2008-03-16
IL194862A0 (en) 2009-08-03
RU2008149242A (ru) 2010-06-27

Similar Documents

Publication Publication Date Title
IL194862A0 (en) Maleate co-crystal of azd1152
ZA200900030B (en) Improvements relating to pharmaceutical compositions
EP2001498A4 (en) PHARMACEUTICAL COMPOSITIONS
IL194176A0 (en) Pharmaceutical compositions
GB0625322D0 (en) Pharmaceutical compositions
IL197869A0 (en) Compositions of chk1 inhibitors
PL2361922T3 (pl) Produkty pośrednie do wytwarzania inhibitorów nukleozydowych HCV
IL195541A0 (en) Pharmaceutical compositions of memantine
HK1138732A1 (en) Pharmaceutical compositions
HK1131130A1 (en) Co-crystals of pyrrolidinones
ZA200905134B (en) Compositions of stable tiacumicins
IL197235A0 (en) Therapeutic compositions
ZA200810178B (en) Pharmaceutical compositions for sustained release of phenyephrine
EP2147715A4 (en) STRUCTURE OF AN ONLINE MIXER
IL198835A0 (en) Pharmaceutical compositions of memantine
TWM298911U (en) Improved structure of slippers
GB201114396D0 (en) Location of basesation
TWM298391U (en) Improved structure of bar
TWM298442U (en) Improved structure of sprinkle-nozzle for fire-extinguisher
TWM311768U (en) Improved structure of A-ladder
TWM300465U (en) Improved structure of shoes
GB0612370D0 (en) Uses of (S)-clenbuterol
TWM299787U (en) Structure of screw
SK232006A3 (sk) Poistenie skrutkového spoja
IL198836A0 (en) Processes for preparation of 9-haloacetamidomidominocyclines